By using these two m-PFMKs, the authors essentially explored the role of the aberrant expression of Cats in renal cancer [23], especially in relation to its aggressiveness and spreading, in such a way as to validate these lysosomal proteases as pharmacological targets. The gene discussed is PIMREG; the disease is renal carcinoma.